| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4
| KINGSLEY ALFRED D (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 30,000 shares
@ $0.2149, valued at
$6.4k
|
|
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/05/2023 |
4
| BROADWOOD PARTNERS, L.P. (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Bought 26,827,638 shares
@ $0.3017, valued at
$8.1M
|
|
| 04/05/2023 |
4
| Gutfreund John Peter (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 705,000 shares
@ $0.3544, valued at
$249.9k
Granted 1,000,000 shares
@ $0.3544, valued at
$354.4k
Disposed/sold 588 convertible preferred
@ $0 |
|
| 04/05/2023 |
4
| Arno Andrew (Director) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 141,084 shares
@ $0.3544, valued at
$50k
Granted 141,084 shares
@ $0.3544, valued at
$50k
Granted 141,084 shares
@ $0.3544, valued at
$50k
|
|
| 03/08/2023 |
4
| PURA VIDA INVESTMENTS, LLC (10% Owner) has filed a Form 4 on Oncocyte Corp|
Txns:
| Disposed of 3,890,111 shares
@ $0 |
|
| 02/28/2023 |
4
| Riggs Josh (CEO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 116,426 options to buy
@ $0.39, valued at
$45.4k
|
|
| 02/28/2023 |
4
| John Anish M. (CFO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 121,381 options to buy
@ $0.39, valued at
$47.3k
|
|
| 01/19/2023 |
4
| Riggs Josh (Interim CEO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 257,485 options to buy
@ $0.4629, valued at
$119.2k
|
|
| 01/19/2023 |
4
| Liu James Yang (Controller, PAO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 57,065 options to buy
@ $0.4629, valued at
$26.4k
|
|
| 01/19/2023 |
4
| John Anish M. (CFO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 250,466 options to buy
@ $0.4629, valued at
$115.9k
|
|
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2022 |
4
| Ross Douglas T. (Former CSO) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 213,797 shares
@ $0 |
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/09/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/22/2022 |
3
| Liu James Yang (Controller, PAO) has filed a Form 3 on Oncocyte Corp |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Ross Douglas T. (Chief Scientific Officer) has filed a Form 4 on Oncocyte Corp|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|